6515--Reprocessed Non-Critical Single Use Devices

quisition strategy, and does not obligate VA to award a contract now or in the future. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of contractor responses to this RFI or the Government s use of such information. Any future procurement will be conducted in accordance with the FAR and the VA Acquisition Regulation (VAAR), including applicable VAAR provisions implementing the Veterans First Contracting Program and other socioeconomic requirements. Responses to this RFI may inform VA s acquisition planning, including potential small business or Veterans First set aside decisions, contract type, and performance-based acquisition approaches, but will not be used as evaluation criteria for any future solicitation. Proprietary and business sensitive information should be clearly marked; VA will handle such information in accordance with applicable laws and regulations. Executive Summary The Department of Veterans Affairs, America s largest integrated healthcare system, is exploring enterprise-wide adoption of FDA cleared third party reprocessing and reutilization of non-critical single use medical devices (SUDs). VA s objectives are to achieve significant cost savings, measurable medical waste reduction, and the highest possible patient safety through robust, scalable, and innovative reprocessing partnerships. To support rigorous acquisition planning and a defensible Independent Government Cost Estimate (IGCE), respondents must provide comprehensive cost and technical information for pilot phase, phased deployment, and full enterprise implementation. VA will prioritize evidence-based safety, interoperability with VA systems, digital integration, supplier diversity (including Veterans First participation), Section 508 accessibility, and a commitment to continuous improvement. This RFI is issued under FAR Part 10 and applicable VAAR provisions governing VA acquisition planning and market research. 1. Strategic Context and Objectives The VA is committed to: Reducing cost and optimizing resource utilization through safe, compliant reprocessing of non critical SUDs. Lowering environmental impact and regulated medical waste. Supporting digital transformation and supply chain modernization. Maximizing value, safety, and effectiveness in patient care for non critical applications. Advancing sustainability, supplier diversity, Veterans First participation, and Section 508 accessibility. Respondents should describe how their solutions align with these objectives and support performance-based acquisition and outcome focused contracting strategies consistent with FAR guidance. 2. Background VA is considering enterprise-wide solutions to reprocess non - critical SUDs (a representative list is provided in Appendix A) and seeks insights, outcomes, and recommendations from vendors serving government, military, or large integrated delivery networks. Robust cost estimates and evidence-based performance data are essential to support VA s business case evaluation, IGCE development, and acquisition planning under FAR/VAAR. 3. RFI Scope VA seeks market input on capabilities, approaches, and pricing models that could inform a future acquisition of enterprise non critical SUD reprocessing services. Areas of interest include: End-to-end collection, secure logistics , chain of custody, and tracking of non critical SUDs from VA facilities (see Appendix A for device types). FDA-cleared reprocessing, cleaning/disinfection, functional validation, relabeling, and safe release for reuse of non critical SUDs. Systems interoperability with VA informatics, supply chain, and EHR platforms, including adherence to Federal and VA standards for data protection and accessibility (e.g., Section 508). Training, onboarding, and change management for VA staff handling non critical SUDs. Environmental and financial impact measurement and transparent reporting specific to non critical SUDs. Detailed cost/pricing models and phased deployment estimates including pilot phase, a multi-year phased implementation resulting in full system implementation. These cost/pricing models should include annualized and cumulative scenarios to inform IGCE development and contract type selection. Data security, adverse event management, recall procedures, and regulatory compliance. Full scale enterprise ramp up, scalability, continuity, supplier diversity, and risk mitigation plans. Commitment to innovation, continuous improvement, and client engagement. 4. Key Definitions and Abbreviations Non-critical SUD: Device intended for one-patient/one-procedure use, contacting only intact skin (not mucous membranes/sterile body sites). FDA-cleared reprocessor: Third-party vendor with FDA 510(k)/PMA for reprocessing non-critical SUDs. QMS:� Quality Management System (e.g., ISO 13485). CAPA: Corrective and Preventive Action. Section 508:� Federal requirement for accessibility. IGCE: Independent Government Cost Estimate. Other acronyms/terms as used herein. 5. Information Requested Please organize your response according to the sections below and reference relevant non-critical SUDs (see Appendix A). Responses should not exceed 20 pages, plus optional appendices. Clearly identify proprietary information and any data that should be treated as business sensitive. Throughout your submission, provide sufficient detail, data, and explanation to allow VA to prepare an IGCE and to assess potentially appropriate contract types and risk allocations under FAR. A. Executive Summary Briefly describe your organization, capabilities, and your vision for VA s non-critical SUD reprocessing program. B. Regulatory Compliance & Quality Keep your existing bullets, and add: Identify any experience with federal healthcare or VA contracts and describe how you ensured compliance with FAR/VAAR requirements, quality standards, and applicable agency policies (no contract numbers needed). Provide FDA clearance documentation for all non-critical SUDs you are authorized to reprocess. Provide a list of non-critical SUDs you are not authorized to reprocess, explaining the rationale for not reprocessing these items. Include your QMS certifications (e.g., ISO 13485), audit/inspection history (last 5 years), and CAPA process. Describe how your Quality Management System and CAPA processes support performance-based contracting, measurable outcomes, and potential quality assurance surveillance by the Government in accordance with FAR principles. Provide sample device labels and chain-of-custody/logistics reports for representative non-critical SUDs. State readiness to comply with VA policies and update your status in response to regulatory changes. Describe anticipated challenges and solutions for addressing non-standard business processes (such as variations in device handling, workflow, collection, and onsite management) and the existence of multiple software systems/platforms across VA points of care. Specify how you will assess, adapt to, and mitigate the risks associated with these process and IT system variations during implementation and system integration. Explain how your proposed risk mitigation strategies for these variations will inform or alter your approach to phased deployment, including pilot planning and scaling to full enterprise adoption. C. Technical Approach, Workflow, and Interoperability Outline y